Christopher Aker - Jan 18, 2024 Form 4 Insider Report for Regulus Therapeutics Inc. (RGLS)

Role: Sr. VP & General Counsel
Signature: Christopher Aker
Stock symbol: RGLS
Transactions as of: Jan 18, 2024
Transactions value $: -$6,510
Form type: 4
Date filed: 1/18/2024, 08:23 PM
Previous filing: Jan 17, 2024
Next filing: May 21, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RGLS	Common Stock	Sale	-$6.51K	-5.47K	-35.22%	$1.19	10.1K	Jan 18, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. These sales are made pursuant to an existing 10b5-1 plan under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.

Content

The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. These sales are made pursuant to an existing 10b5-1 plan under which the Reporting Person has irrevocably elected to satisfy the tax obligations through this sale and do not represent discretionary trades by the Reporting Person.